MedMira Receives Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, June 6, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent (number 11,353,450)...
MedMira Receives Patent for its Unique Quantitative Diagnostic System
Update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market
VYRA™ Product Line Update
Test yourself in a smart way
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test
Practical Testing